Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options

Pankaj Tiwari, Michelle Coriddi, Ritu Salani, Stephen P Povoski, Pankaj Tiwari, Michelle Coriddi, Ritu Salani, Stephen P Povoski

Abstract

Lymphedema remains a poorly understood entity that can occur after lymphadenectomy. Herein, we will review the pathogenesis of lymphedema, diagnostic modalities and the natural history of extremity involvement. We will review the incidence of upper extremity lymphedema in patients treated for breast malignancies and lower extremity lymphedema in those treated for gynecologic malignancy. Finally, we will review traditional treatment modalities for lymphedema, as well as introduce new surgical treatment modalities that are under active investigation.

Figures

Figure 1
Figure 1
Left upper extremity lymphedema in a patient treated for breast cancer with modified radical mastectomy and axillary radiation treatment.
Figure 2
Figure 2
Right lower extremity lymphedema in a patient treated for endometrial cancer with lymphadenectomy and radiation treatment.
Figure 3
Figure 3
Design for submental lymph node flap based on the submental vessels branching from the facial vessels. The flap design is identical to a submental flap as used for head/neck reconstruction.
Figure 4
Figure 4
Intraoperative view of cervical lymph node flap (level I) identifying submental vessels and facial nerve.
Figure 5
Figure 5
Design of a planned cervical lymph node flap (level V) based on transverse cervical vessels. Depicts sites of indocyanine green injection for intraoperative lymph node identification. The flap is based on the transverse cervical vessels located at the junction of the medial and middle thirds of the clavicle.
Figure 6
Figure 6
Patient with a history of vulvar carcinoma who has undergone superficial lymphadenectomy and resulting lower extremity lymphedema. Incision design for elevation of vascularized lymph node flap based on thoracodorsal vessels and incision design for abdominal incision for inset of flap (black arrows). Green arrows indicate sites of injection of indocyanine green to identify lymph nodes draining the chest for inclusion in the flap. Red arrow indicates the site for inset of the vascularized lymph node flap above the muscular fascia in the region of superficial lymphadenectomy. The patient had undergone technetium injection into the left hand the day prior to surgery in order to identify lymph nodes draining this extremity ('reverse lymphatic mapping’).
Figure 7
Figure 7
Intraoperative view of lymph node flap based on thoracodorsal artery and vein. The picture depicts the lower chest thoracic lymph nodes located at Level III axillary lymph node position. These lymph nodes did not take up technetium, thereby avoiding the extremity drainage basin.

References

    1. Ellis S. Structure and function of the lymphatic system: an overview. Br J Community Nurs. 2006;11:S4–S6.
    1. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59:464–472. doi: 10.1097/01.sap.0000257149.42922.7e.
    1. The International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. 2009 consensus document of the International Society of Lymphology. Lymphology. 2009;42:51–60.
    1. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer. 2005;104:457–466. doi: 10.1002/cncr.21195.
    1. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics. 1985;76:206–218.
    1. Rockson G. Lymphatics in the digestive system: physiology, health and disease. Ann NY Acad Sci. 2010;1207(S1):E2–E6.
    1. Meneses KD, McNees MP. Upper extremity lymphedema after treatment for breast cancer: a review of the literature. Ostomy Wound Manage. 2007;53:16–29.
    1. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–1377. doi: 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>;2-9.
    1. Murdaca G, Cagnati P, Gulli R, Spanò F, Puppo F, Campisi C, Boccardo F. Current views on diagnostic approach and treatment of lymphedema. Am J Med. 2012;125:134–140. doi: 10.1016/j.amjmed.2011.06.032.
    1. Lin S, Kim J, Lee MJ, Roche L, Yang NL, Tsao PS, Rockson SG. Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One. 2012;7:e52021. doi: 10.1371/journal.pone.0052021.
    1. Avraham T, Zampell JC, Yan A, Elhadad S, Weitman ES, Rockson SG, Bromberg J, Mehrara BJ. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J. 2013;27:1114–1126. doi: 10.1096/fj.12-222695.
    1. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–379. doi: 10.1097/00006199-200311000-00004.
    1. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.
    1. Kramer EL. Lymphoscintigraphy: defining a clinical role. Lymphat Res Biol. 2004;2:32–37. doi: 10.1089/1539685041690454.
    1. Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008;52:799–806. doi: 10.1016/j.jacc.2008.06.005.
    1. Vaughan BF. CT of swollen legs. Clin Radiol. 1990;41:24–30. doi: 10.1016/S0009-9260(05)80927-4.
    1. Dimakakos PB, Stefanopoulos T, Antoniades P, Antoniou A, Gouliamos A, Rizos D. MRI and ultrasonographic findings in the investigation of lymphedema and lipedema. Int Surg. 1997;82:411–416.
    1. Matsushima S, Ichiba N, Hayashi D, Fukuda K. Nonenhanced magnetic resonance lymphoductography: visualization of lymphatic system of the trunk on 3-dimensional heavily T2-weighted image with 2-dimensional prospective acquisition and correction. J Comput Assist Tomogr. 2007;31:299–302. doi: 10.1097/01.rct.0000236415.97642.58.
    1. Lohrmann C, Foeldi E, Bartholomae JP, Langer M. Gadoteridol for MR imaging of lymphatic vessels in lymphoedematous patients: initial experience after intracutaneous injection. Br J Radiol. 2007;80:569–573. doi: 10.1259/bjr/95414884.
    1. Arrive L, Azizi L, Lewin M, Hoeffel C, Monnier-Cholley L, Lacombe C, Tubiana JM. MR lymphography of abdominal and retroperitoneal lymphatic vessels. AJR Am J Roentgenol. 2007;189:1051–1058. doi: 10.2214/AJR.07.2047.
    1. Yamamoto T, Narushima M, Doi K, Oshima A, Ogata F, Mihara M, Koshima I, Mundinger GS. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconst Surg. 2011;127:1979–1986. doi: 10.1097/PRS.0b013e31820cf5df.
    1. Yamamoto T, Yamamoto N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I. Indocyanine green (ICG)-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow (DB) patterns. Plast Reconstr Surg. 2011;128:941–947. doi: 10.1097/PRS.0b013e3182268cd9.
    1. Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I. The earliest finding of indocyanine green (ICG) lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow (DB) stage and concept of subclinical lymphedema. Plast Reconstr Surg. 2011;128:314e–321e. doi: 10.1097/PRS.0b013e3182268da8.
    1. Akita S, Mitsukawa N, Rikihisa N, Kubota Y, Omori N, Mitsuhashi A, Tate S, Shozu M, Satoh K. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg. 2013;131:283–289. doi: 10.1097/PRS.0b013e318277870f.
    1. Yamamoto T, Iida T, Matsuda N, Kikuchi K, Yoshimatsu H, Mihara M, Narushima M, Koshima I. Indocyanine green (ICG) enhanced lymphography for evaluation of facial lymphoedema. J Plast Reconstr Aesthet Surg. 2011;64:1541–1544. doi: 10.1016/j.bjps.2011.05.025.
    1. Warren AG, Janz BA, Slavin SA, Borud LJ. The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg. 2007;58:541–543. doi: 10.1097/.
    1. American Cancer Society. Cancer Facts & Figures 2013. .
    1. American Cancer Society. Cancer Treatment and Survivorship, Facts and Figures. 2012. .
    1. Morcos BB, Al Ahmad F, Anabtawi I, Abu Sbá AM, Shabani H, Yaseen R. Lymphedema. A significant health problem for women with breast cancer in Jordan. Saudi Med J. 2013;34:62–66.
    1. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15:153–165. doi: 10.1016/j.suronc.2006.11.003.
    1. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa women’s health study. Breast Cancer Res Treat. 2011;130:981–991. doi: 10.1007/s10549-011-1667-z.
    1. Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast. 2012;21:361–365. doi: 10.1016/j.breast.2012.03.002.
    1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553. doi: 10.1056/NEJMoa012782.
    1. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N. National Surgical Adjuvant Breast, Bowel Project. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102:111–118. doi: 10.1002/jso.21535.
    1. Ridner SH, Sinclair V, Deng J, Bonner CM, Kidd N, Dietrich MS. Breast cancer survivors with lymphedema: glimpses of their daily lives. Clin J Oncol Nurs. 2012;16:609–614. doi: 10.1188/12.CJON.609-614.
    1. Greenslade MV, House CJ. Living with lymphedema: a qualitative study of women’s perspectives on prevention and management following breast cancer-related treatment. Can Oncol Nurs J. 2006;16:165–179. doi: 10.5737/1181912x163165171.
    1. Ridner SH, Bonner CM, Deng J, Sinclair VG. Voices from the shadows: living with lymphedema. Cancer Nurs. 2012;35:E18–E26. doi: 10.1097/NCC.0b013e31821404c0.
    1. Gärtner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment–a nationwide study of prevalence and associated factors. Breast. 2010;19:506–515. doi: 10.1016/j.breast.2010.05.015.
    1. Chachaj A, Małyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudełko M, Andrzejak R, Szuba A. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology. 2010;19:299–305. doi: 10.1002/pon.1573.
    1. Suami H, Chang DW. Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg. 2010;126:1853–1863. doi: 10.1097/PRS.0b013e3181f44658.
    1. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28:609–613.
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013 Mar;46(1):1–11.
    1. Dominick SA, Madlensky L, Natarajan L, Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL Study. J Cancer Surviv. 2013;7:115–123. doi: 10.1007/s11764-012-0251-9.
    1. Quirion E. Recognizing and treating upper extremity lymphedema in postmastectomy/lumpectomy patients: a guide for primary care providers. J Am Acad Nurse Pract. 2010;22:450–459. doi: 10.1111/j.1745-7599.2010.00542.x.
    1. Park JE, Jang HJ, Seo KS. Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann Rehabil Med. 2012;36:240–247. doi: 10.5535/arm.2012.36.2.240.
    1. Rourke LL, Hunt KK, Cormier JN. Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond Engl) 2010;6:399–406. doi: 10.2217/whe.10.21.
    1. McLaughlin SA. Lymphedema: separating fact from fiction. Oncology (Williston Park) 2012;26:242–249.
    1. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007–2014. doi: 10.1200/JCO.2008.18.3517.
    1. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc. 2005;80:1480–1484. doi: 10.4065/80.11.1480.
    1. Shah C, Arthur D, Riutta J, Whitworth P, Vicini FA. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction. Breast J. 2012;18:357–361. doi: 10.1111/j.1524-4741.2012.01252.x.
    1. Chang DW, Kim S. Breast reconstruction and lymphedema. Plast Reconstr Surg. 2010;125:19–23.
    1. Avraham T, Daluvoy SV, Riedel ER, Cordeiro PG, Van Zee KJ, Mehrara BJ. Tissue expander breast reconstruction is not associated with an increased risk of lymphedema. Ann Surg Oncol. 2010;17:2926–2932. doi: 10.1245/s10434-010-1112-2.
    1. Card A, Crosby MA, Liu J, Lindstrom WA, Lucci A, Chang DW. Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone. Plast Reconstr Surg. 2012;130:1169–1178. doi: 10.1097/PRS.0b013e31826d0faa.
    1. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19:853–857. doi: 10.1007/s00520-011-1089-9.
    1. Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J. 2010;16:48–54. doi: 10.1111/j.1524-4741.2009.00855.x.
    1. Soran A, D’Angelo G, Begovic M, Ardic F, Harlak A, Samuel Wieand H, Vogel VG, Johnson RR. Breast cancer-related lymphedema–what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006;12:536–543. doi: 10.1111/j.1524-4741.2006.00342.x.
    1. Pezner RD, Patterson MP, Hill R, Lipsett JA, Desai KR, Vora N, Wong JY, Luk KH. Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys. 1986;12:2079–2083. doi: 10.1016/0360-3016(86)90005-2.
    1. Gho SA, Steele JR, Jones SC, Munro BJ. Self-reported side effects of breast cancer treatment: a cross-sectional study of incidence, associations, and the influence of exercise. Cancer Causes Control. 2013;24:517–528. doi: 10.1007/s10552-012-0142-4.
    1. Newman B, Lose F, Kedda MA, Francois M, Ferguson K, Janda M, Yates P, Spurdle AB, Hayes SC. Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol. 2012;10:2–13. doi: 10.1089/lrb.2011.0024.
    1. Shah C, Wilkinson JB, Baschnagel A, Ghilezan M, Riutta J, Dekhne N, Balaraman S, Mitchell C, Wallace M, Vicini F. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2012;83:1095–1100. doi: 10.1016/j.ijrobp.2011.09.058.
    1. Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey CL, Danoff JV, Gerber LH, Soballe PW. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92:152–163. doi: 10.2522/ptj.20100167.
    1. Kwan ML, Shen L, Munneke JR, Tam EK, Partee PN, André M, Kutner SE, Somkin CP, Ackerson LM, Thiadens SR. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012;135:591–602. doi: 10.1007/s10549-012-2199-x.
    1. Ridner SH, Dietrich MS, Kidd N. Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer. 2011;19:631–637. doi: 10.1007/s00520-010-0870-5.
    1. Fu MR, Chen CM, Haber J, Guth AA, Axelrod D. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann Surg Oncol. 2010;17:1847–1853. doi: 10.1245/s10434-010-0941-3.
    1. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010;145:1055–1063. doi: 10.1001/archsurg.2010.231.
    1. Sisman H, Sahin B, Duman BB, Tanriverdi G. Nurse-assisted education and exercise decrease the prevalence and morbidity of lymphedema following breast cancer surgery. J BUON. 2012;17:565–569.
    1. Armer JM, Shook RP, Schneider MK, Brooks CW, Peterson J, Stewart BR. Enhancing supportive-educative nursing systems to reduce risk of post-breast cancer lymphedema. Self Care Depend Care Nurs. 2009;17:6–15.
    1. Tiwari P, Coriddi M, Lamp S. Lymphedema strategies for investigation and treatment: a review. Plast Surg Nurs. 2012;32:173–177. doi: 10.1097/PSN.0b013e318275e7bd.
    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:9–11. doi: 10.3322/caac.21169.
    1. Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T. The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum. 2003;30:417–423. doi: 10.1188/03.ONF.417-423.
    1. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment. Cancer. 2007;109:2607–2614. doi: 10.1002/cncr.22684.
    1. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103:714–718. doi: 10.1016/j.ygyno.2006.03.055.
    1. Wenzel L. Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy—what is the next step? Gynecol Oncol. 2009;113:299–300. doi: 10.1016/j.ygyno.2009.04.015.
    1. Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients’ quality of life: a qualitative assessment. Int Jour Gynecol Cancer. 2004;14:875–881. doi: 10.1111/j.1048-891X.2004.14524.x.
    1. Novackova M, Halaska MJ, Robova H, Mala I, Pluta M, Chmel R, Rob L. A prospective study in detection of lower-limb lymphedema and evaluation of quality of life after vulvar cancer surgery. Int J Gynecol Cancer. 2012;22:1081–1088. doi: 10.1097/IGC.0b013e31825866d0.
    1. Newman ML, Brennan M, Passik S. Lymphedema complicated by pain and psychological distress: a case with complex treatment needs. J Pain Symptom Manage. 1996;12:376–379. doi: 10.1016/S0885-3924(96)00187-X.
    1. Franks PJ, Moffatt CJ, Doherty DC, Williams AF, Jeffs E, Mortimer PS. Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen. 2006;14:110–118. doi: 10.1111/j.1743-6109.2006.00099.x.
    1. Jager G, Doller W, Roth R. Quality of life and body image impairments in patients with lymphedema. Lymphology. 2006;39:193–200.
    1. Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR. A pilot study using the gynecologic cancer lymphedema questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol. 2010;117:317–323. doi: 10.1016/j.ygyno.2010.01.022.
    1. Carlson JW, Kauderer J, Walker JL, Gold MA, O’Malley D, Tuller E, Clarke-Pearson DL. Gynecologic Oncology Group. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a gynecologic oncology group study. Gynecol Oncol. 2008;110:76–82. doi: 10.1016/j.ygyno.2008.03.005.
    1. Hinten F, van den Einden LC, Hendriks JC, van der Zee AG, Bulten J, Massuger LF, van de Nieuwenhof HP, de Hullu JA. Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br J Cancer. 2011;105:1279–1287. doi: 10.1038/bjc.2011.407.
    1. Zhang X, Sheng X, Niu J, Li H, Li D, Tang L, Li Q, Li Q. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol. 2007;105:722–726. doi: 10.1016/j.ygyno.2007.02.011.
    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi: 10.3322/caac.20138.
    1. Walker KF, Day H, Abu J, Nunns D, Williamson K, Duncan T. Do surgical techniques used in groin lymphadenectomy for vulval cancer affect morbidity rates? Int J Gynecol Cancer. 2011;21:1495–1499. doi: 10.1097/IGC.0b013e318228f314.
    1. Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–579.
    1. McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5213–5219. doi: 10.1200/JCO.2008.16.3725.
    1. Moore RG, Robison K, Brown AK, DiSilvestro P, Steinhoff M, Noto R, Brard L, Granai CO. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol. 2008;109:65–70. doi: 10.1016/j.ygyno.2007.12.027.
    1. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–889. doi: 10.1200/JCO.2007.14.0566.
    1. Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol. 2009;113:301–305. doi: 10.1016/j.ygyno.2008.12.006.
    1. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16:1130–1139. doi: 10.1111/j.1525-1438.2006.00601.x.
    1. Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47. doi: 10.1186/1471-2407-9-47.
    1. Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, Aoyagi Y, Ohba Y, Okamoto K, Kato H. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119:60–64. doi: 10.1016/j.ygyno.2010.06.018.
    1. Hareyama H, Ito K, Hada K, Uchida A, Hayakashi Y, Hirayama E, Oikawa M, Okuyama K. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies. Ann Surg Oncol. 2012;19:268–273. doi: 10.1245/s10434-011-1863-4.
    1. Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011;117:948–956. doi: 10.1002/cncr.25544.
    1. Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lécuru F. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39:81–86. doi: 10.1016/j.ejso.2012.10.011.
    1. Werngren-Elgstrom M, Lidman D. Lymphedema of the lower extremities after surgery and radiotherapy for cancer of the cervix. Scand J Plast Reconstr Surg Hand Surg. 1994;28:289–293. doi: 10.3109/02844319409022014.
    1. Füller J, Guderian D, Köhler C, Schneider A, Wendt TG. Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:206–211. doi: 10.1007/s00066-008-1728-3.
    1. Abu-Rustum NR, Barakat RR. Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. Gynecol Oncol. 2007;106:4–5. doi: 10.1016/j.ygyno.2007.03.026.
    1. Ohba Y, Todo Y, Kobayashi N, Kaneuchi M, Watari H, Takeda M, Sudo S, Kudo M, Kato H, Sakuragi N. Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol. 2011;16:238–243. doi: 10.1007/s10147-010-0171-5.
    1. Kim JH, Choi JH, Ki EY, Lee SJ, Yoon JH, Lee KH, Park TC, Park JS, Bae SN, Hur SY. Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Gynecol Cancer. 2012;22:686–691. doi: 10.1097/IGC.0b013e3182466950.
    1. Halaska MJ, Novackova M, Mala I, Pluta M, Chmel R, Stankusova H, Robova H, Rob L. A prospective study of postoperative lymphedema after surgery for cervical cancer. Int J Gynecol Cancer. 2010;20:900–904. doi: 10.1111/IGC.0b013e3181da29d0.
    1. Wang PL, Cheng YB, Kuerban G. The clinical characteristic differences between thrombosis-related edema and lymphedema following radiotherapy or chemoradiotherapy for patients with cervical cancer. J Radiat Res. 2012;53:125–129. doi: 10.1269/jrr.11094.
    1. Greene AK, Grant FD, Slavin SA. Lower-extremity lymphedema and elevated body-mass index. N Engl J Med. 2012;366:2136–2137.
    1. Fujiwara K, Kigawa J, Hasegawa K, Nishimura R, Umezaki N, Ando M, Itamochi H, Yamaguchi S, Oda T, Terakawa N, Kohshima I, Kohno I. Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy. Int J Gynecol Cancer. 2003;13:61–66. doi: 10.1046/j.1525-1438.2003.13029.x.
    1. Khoury-Collado F, Murray MP, Hensley ML, Sonoda Y, Alektiar KM, Levine DA, Leitao MM, Chi DS, Barakat RR, Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol. 2011;122:251–254. doi: 10.1016/j.ygyno.2011.04.030.
    1. Niikura H, Okamoto S, Otsuki T, Yoshinaga K, Utsunomiya H, Nagase S, Takano T, Ito K, Watanabe M, Yaegashi N. Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer. Int J Gynecol Cancer. 2012;22:1244–1250. doi: 10.1097/IGC.0b013e318263f06a.
    1. Langbecker D, Hayes SC, Newman B, Janda M. Treatment for upper limb and lower limb lymphedema by professionals specializing in lymphedema care. Eur J Cancer Care. 2008;17:557–564.
    1. Mayrovitz HN, Macdonald J, Davey S, Olson K, Washington E. Measurement decisions for clinical assessment of limb volume changes in patients with bilateral and unilateral limb edema. Phys Ther. 2007;87:1362–1368. doi: 10.2522/ptj.20060382.
    1. Lu Q, Delproposto Z, Hu A, Tran C, Liu N, Li Y, Xu J, Bui D, Hu J. MR lymphography of lymphatic vessels in lower extremity with gynecologic oncology-related lymphedema. PLoS One. 2012;7:e50319. doi: 10.1371/journal.pone.0050319.
    1. Soliman AA, Heubner M, Kimmig R, Wimberger P. Morbidity of inguinofemoral lymphadenectomy in vulval cancer. Sci World J. 2012;2012:341253.
    1. Sawan S, Mugnai R, Lopes Ade B, Hughes A, Edmondson RJ. Lower-limb lymphedema and vulval cancer: feasibility of prophylactic compression garments and validation of leg volume measurement. Int J Gynecol Cancer. 2009;19:1649–1654. doi: 10.1111/IGC.0b013e3181a8446a.
    1. Rockson SG, Miller LT, Senie R, Brennan MJ, Casley-Smith JR, Földi E, Földi M, Gamble GL, Kasseroller RG, Leduc A, Lerner R, Mortimer PS, Norman SA, Plotkin CL, Rinehart-Ayres ME, Walder AL. American Cancer Society lymphedema workshop: workgroup III: diagnosis and management of lymphedema. Cancer. 1998;83:2882–2885. doi: 10.1002/(SICI)1097-0142(19981215)83:12B+<2882::AID-CNCR45>;2-0.
    1. Olszewski WL, Engeset A. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol. 1980;239:H775–H783.
    1. Cormier JN, Rourke L, Crosby M, Chang D, Armer J. The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004–2010) Ann Surg Oncol. 2012;19:642–651. doi: 10.1245/s10434-011-2017-4.
    1. Salgado CJ. Radical reduction of upper extremity lymphedema with preservation of perforators. Ann Plast Surg. 2009;63:302–306. doi: 10.1097/SAP.0b013e31818d45aa.
    1. Karri V, Yang MC, Lee IJ, Chen SH, Hong JP, Xu ES, Cruz-Vargas J, Chen HC. Optimizing outcome of charles procedure for chronic lower extremity lymphedema. Ann Plast Surg. 2011;66:393–402. doi: 10.1097/SAP.0b013e3181d6e45e.
    1. Doscher ME, Herman S, Garfein ES. Surgical management of inoperable lymphedema: the re-emergence of abandoned techniques. J Am Coll Surg. 2012;215:278–283. doi: 10.1016/j.jamcollsurg.2012.03.020.
    1. van der Walt JC, Perks TJ, Zeeman BJ, Bruce-Chwatt AJ, Graewe FR. Modified Charles procedure using negative pressure dressings for primary lymphedema: a functional assessment. Ann Plast Surg. 2009;62:669–675. doi: 10.1097/SAP.0b013e318180cd24.
    1. Lee BB, Kim YW, Kim DI, Hwang JH, Laredo J, Neville R. Supplemental surgical treatment to end stage (stage IV-V) of chronic lymphedema. Int Angiol. 2008;27:389–395.
    1. Modolin M, Mitre AI, da Silva JC, Cintra W, Quagliano AP, Arap S, Ferreira MC. Surgical treatment of lymphedema of the penis and scrotum. Clinics (Sao Paulo) 2006;61:289–294. doi: 10.1590/S1807-59322006000400003.
    1. Damstra RJ, Voesten HG, Klinkert P, Brorson H. Circumferential suction-assisted lipectomy for lymphoedema after surgery for breast cancer. Br J Surg. 2009;96:859–864. doi: 10.1002/bjs.6658.
    1. Brorson H, Ohlin K, Olsson G, Långström G, Wiklund I, Svensson H. Quality of life following liposuction and conservative treatment of arm lymphedema. Lymphology. 2006;39:8–25.
    1. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102:1058–1067.
    1. Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg. 2003;92:287–295.
    1. Greene AK, Slavin SA, Borud L. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg. 2006;118:118e–121e. doi: 10.1097/01.prs.0000237020.29209.22.
    1. Schaverien MV, Munro KJ, Baker PA, Munnoch DA. Liposuction for chronic lymphoedema of the upper limb: 5 years of experience. J Plast Reconstr Aesthet Surg. 2012;65:935–942. doi: 10.1016/j.bjps.2012.01.021.
    1. Taylor SM, Brake M. Liposuction for the management of submental lymphedema in the head and neck cancer patient. Otolaryngol Head Neck Surg. 2012;146:1028–1030. doi: 10.1177/0194599812438337.
    1. Brorson H. From lymph to fat: liposuction as a treatment for complete reduction of lymphedema. Int J Low Extrem Wounds. 2012;11:10–19. doi: 10.1177/1534734612438550.
    1. O’Brien BM, Mellow CG, Khazanchi RK, Dvir E, Kumar V, Pederson WC. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg. 1990;85:562–572. doi: 10.1097/00006534-199004000-00011.
    1. Yamamoto Y, Sugihara T. Microsurgical lymphaticovenous implantation for the treatment of chronic lymphedema. Plast Reconstr Surg. 1998;101:157–161. doi: 10.1097/00006534-199801000-00026.
    1. Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg. 2010;126:752–758. doi: 10.1097/PRS.0b013e3181e5f6a9.
    1. Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema: a prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2009;113:199–206. doi: 10.1007/s10549-008-9932-5.
    1. Demirtas Y, Ozturk N, Yapici O, Topalan M. Supermicrosurgical lymphaticovenular anastomosis and lymphaticovenous implantation for treatment of unilateral lower extremity lymphedema. Microsurgery. 2009;29:609–618. doi: 10.1002/micr.20665.
    1. Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30:256–260.
    1. Koshima I, Inagawa K, Urushibara K, Moriguchi T. Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities. J Reconstr Microsurg. 2000;16:437–442. doi: 10.1055/s-2006-947150.
    1. Yamamoto T, Narushima M, Kikuchi K, Yoshimatsu H, Todokoro T, Mihara M, Koshima I. Lambda-shaped anastomosis with intravascular stenting method for safe and effective lymphaticovenular anastomosis. Plast Reconstr Surg. 2011;127:1987–1992. doi: 10.1097/PRS.0b013e31820cf5c6.
    1. Yamamoto T, Narushima M, Yoshimatsu H, Seki Y, Yamamoto N, Oka A, Hara H, Koshima I. Minimally invasive lymphatic supermicrosurgery (MILS): indocyanine green lymphography-guided simultaneous multi-site lymphaticovenular anastomoses via millimeter skin incisions. Ann Plast Surg. in press.
    1. Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Itoh S. Long-term follow-up after lymphaticovenular anastomosis for lymphedema in the leg. J Reconstr Microsurg. 2003;19:209–215.
    1. Yamamoto T, Yoshimatsu H, Yamamoto N, Narushima M, Iida T, Koshima I. Side-to-end lymphaticovenular anastomosis through temporary lymphatic expansion. PLoS ONE. 2013;8:e59523. doi: 10.1371/journal.pone.0059523.
    1. Auba C, Marre D, Rodríguez-Losada G, Hontanilla B. Lymphaticovenular anastomoses for lymphedema treatment: 18 months postoperative outcomes. Microsurgery. 2012;32:261–268. doi: 10.1002/micr.20980.
    1. Cheng MH, Huang JJ, Nguyen DH, Saint-Cyr M, Zenn MR, Tan BK, Lee CL. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol. 2012;126:93–98. doi: 10.1016/j.ygyno.2012.04.017.
    1. Lin CH, Ali R, Chen SC, Wallace C, Chang YC, Chen HC, Cheng MH. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg. 2009;123:1265–1275. doi: 10.1097/PRS.0b013e31819e6529.
    1. Viitanen TP, Mäki MT, Seppänen MP, Suominen EA, Saaristo AM. Donor site lymphatic function after microvascular lymph node transfer. Plast Reconstr Surg. 2012;130:1246–1253. doi: 10.1097/PRS.0b013e31826d1682.
    1. Saaristo AM, Niemi TS, Viitanen TP, Tervala TV, Hartiala P, Suominen EA. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg. 2012;255:468–473. doi: 10.1097/SLA.0b013e3182426757.
    1. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243:313–315. doi: 10.1097/01.sla.0000201258.10304.16.
    1. Vignes S, Blanchard M, Yannoutsos A, Arrault M. Complications of autologous lymph-node transplantation for limb lymphoedema. Eur J Vasc Endovasc Surg. 2013;45:516–520. doi: 10.1016/j.ejvs.2012.11.026.
    1. Dayan J. Surgical management of lymphedema: Podium presentation at the American Society of Reconstructive Microsurgery. Florida: Naples; 2013.
    1. Thompson M, Korourian S, Henry-Tilman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890–1895. doi: 10.1245/s10434-007-9412-x.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir